Increased pulse wave velocity and relationship with inflammation, insulin, and insulin resistance in inflammatory bowel disease

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 7, 2014, Pages 725-732

  Korkmaz, Huseyin ^a   Sahin, Fatih ^a   Ipekci, Suleyman H ^a   Temel, Tuncer ^b   Kebapcilar, Levent ^a  

^a SELCUK UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Arterial stiffness; Homocysteine; Inflammatory bowel disease; Insulin resistance; Pulse wave velocity

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SALICYLIC ACID DERIVATIVE; STEROID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CECUM DISEASE; CHOLESTEROL BLOOD LEVEL; COLON DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HOMEOSTASIS; HUMAN; ILEUM DISEASE; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INVASIVE BLOOD PRESSURE MONITOR; OSCILLOMETRY; PANCOLITIS; PRIORITY JOURNAL; PULSE WAVE; QUESTIONNAIRE; REMISSION; ARTERIAL STIFFNESS; BLOOD; BLOOD FLOW VELOCITY; COLITIS, ULCERATIVE; CROHN DISEASE; IMMUNOLOGY; METABOLISM; NONPARAMETRIC TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PULSATILE FLOW; RISK FACTOR; STATISTICAL MODEL;

ADULT; BLOOD FLOW VELOCITY; BLOOD SEDIMENTATION; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; HOMEOSTASIS; HOMOCYSTEINE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED; PULSATILE FLOW; RISK FACTORS; STATISTICS, NONPARAMETRIC; VASCULAR STIFFNESS;

EID: 84902209342     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000104     Document Type: Article

References (42)

1. Hatoum OA, Binion DG. The vasculature and inflammatory bowel disease: contribution to pathogenesis and clinical pathology. Inflamm Bowel Dis 2005; 11:304-313.
2. Hatoum OA, Miura H, Binion DG. The vascular contribution in the pathogenesis of inflammatory bowel disease. Am J Physiol Heart Circ Physiol 2003; 285:1791-1796.
3. Park S, Lakatta EG. Role of inflammation in the pathogenesis of arterial stiffness. Yonsei Med J 2012; 53:258-261.
4. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336:973-979.
5. Roman MJ, Devereux RB, Schwartz JE, Lockshin MD, Paget SA, Davis A, et al. Arterial stiffness in chronic inflammatory diseases. Hypertension 2005; 46:194-199.
6. Yilmaz S, Celik G, Esmen SE. Assessment of arterial stiffness patients with inactive and active Behçet's disease. Scand J Rheumatol 2013; 9:1-7.
7. Dagli N, Poyrazoglu OK, Dagli AF, Sahbaz F, Karaca I, Kobat MA, Bahcecioglu IH. Is inflammatory bowel disease a risk factor for early atherosclerosis? Angiology 2010; 61:198-204.
8. Danese S, Sgambato A, Papa A, Scaldaferri F, Pola R, Sans M, et al. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol 2005; 100:886-895.
9. Bregenzer N, Hartmann A, Strauch U, Schölmerich J, Andus T, Bollheimer LC. Increased insulin resistance and beta cell activity in patients with Crohn's disease. Inflamm Bowel Dis 2006; 12:53-56.
10. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25:932-943.
11. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement. Validation and clinical application studies. Hypertension 1995; 26:485-490.
12. Luzardo L, Lujambio I, Sottolano M, da Rosa A, Thijs L, Noboa O, et al. 24-h ambulatory recording of aortic pulse wave velocity and central systolic augmentation: a feasibility study. Hypertens Res 2012; 35:980-987.
13. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
14. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113:657-663.
15. Zanoli L, Cannavo M, Rastelli S, Di Pino L, Monte I, Di Gangi M, et al. Arterial stiffness is increased in patients with inflammatory bowel disease. J Hypertens 2012; 30:1775-1881.
16. Rachmilewitz D. Coated mesalazine (5-Aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ 1989; 29:82-86.
17. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-Aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med 1987; 317:1625-1629.
18. Best WR, Becktel JM, Singleton JW, Kern FJR. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976; 70:439-444.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
20. Protogerou AD, Argyris A, Nasothimiou E, Vrachatis D, Papaioannou TG, Tzamouranis D, et al. Feasibility and reproducibility of noninvasive 24-h ambulatory aortic blood pressure monitoring with a brachial cuff-based oscillometric device. Am J Hypertens 2012; 25:876-882.
21. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, Eber B. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation 2004; 109:184-189.
22. Wassertheurer S, Kropf J,Weber T, van der Giet M, Baulmann J, Ammer M, et al. A new oscillometric method for pulse wave analysis: comparison with a common tonometric method. J Hum Hypertens 2010; 24:498-504.
23. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, Laurent S. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension 2002; 39:10-15.
24. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 2007; 14 (Suppl 2):E1-E40.
25. Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation 2005; 112:2193-2200.
26. Geerling BJ, Badart-Smook A, Stockbrügger RW, Brummer RJ. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 2000; 54:514-521.
27. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterol 2003; 98:1556-1562.
28. Yarur AJ, Deshpande AR, Pechman DM, Tamariz L, Abreu MT, Sussman DA. Inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol 2011; 106:741-747.
29. Haapamäki J, Roine RP, Turunen U, FärkkiläMA, Arkkila PE. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. J Crohns Colitis 2011; 5:41-47.
30. Akdoǧan RA, Durakoǧlugil ME, Kocaman SA, Çiçek Y, Durakoǧlugil T, Ergül E, Rakici H. Increased pulse wave velocity and carotid intima-media thickness in patients with ulcerative colitis. Dig Dis Sci 2013; 58: 2293-2300.
31. Lentz SR. Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 2005; 3:1646-1654.
32. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102:2165-2168.
33. Mattace-Raso FU, van der Cammen TJ, van der Meer IM, Schalekamp MA, Asmar R, Hofman A,Witteman JC. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis 2004; 176:111-116.
34. Boos CJ, Lip GY. Elevated high-sensitive C-reactive protein, large arterial stiffness and atherosclerosis: a relationship between inflammation and hypertension? J Hum Hypertens 2005; 19:511-513.
35. Samson RH, Yungst Z, Showalter DP. Homocysteine, a risk factor for carotid atherosclerosis, is not a risk factor for early recurrent carotid stenosis following carotid endarterectomy. Vasc Endovascular Surg 2004; 38: 345-348.
36. Papatheodorou L, Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal 2007; 9:1941-1958.
37. Blacher J, Demuth K, Guerin AP, Safar ME, Moatti N, London GM. Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease. Arterioscler Thromb Vasc Biol 1998; 18:535-541.
38. Tayama J, Munakata M, Yoshinaga K, Toyota T. Higher plasma homocysteine concentration is associated with more advanced systemic arterial stiffness and greater blood pressure response to stress in hypertensive patients. Hypertens Res 2006; 29:403-409.
39. Levy D, Hwang SJ, Kayalar A, Benjamin EJ, Vasan RS, Parise H, et al. Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study. Circulation 2007; 115:3079-3085.
40. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Meigs JB, et al. Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in Caucasian subjects from the general population: the Bruneck study. Diabetes Care 2007; 30:318-324.
41. Rantala AO, Päivansalo M, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesäniemi YA. Hyperinsulinemia and carotid atherosclerosis in hypertensive and control subjects. Diabetes Care 1998; 21:1188-1193.
42. Frayn KN. Insulin resistance and lipid metabolism. Curr Opin Lipidol 1993; 4:197-204.